Apremilast

Details

Files

Generic Name:

Apremilast

Project Status:

Complete

Therapeutic Area:

Plaque psoriasis

Manufacturer:

Celgene

Call for patient/clinician input open:

September 4, 2014

Brand Name:

Otezla

Project Line:

Reimbursement Review

Project Number:

SR0400-000

Call for patient/clinician input closed:

October 24, 2014

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Psoriasis, moderate to severe plaque

Recommendation Type:

Do not list

Final Recommendation:

July 22, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Last Updated : October 8, 2014